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Introduction
Rapid and efficient tissues repair after trauma-induced immunological injury is critical for preventing infections 1 .
Wound healing, both after surgery or tissue injury, is mediated by many different cell types and it is dependent on the production of cytokines and growth factors, as well as adequate nutritional support 2 . The healing process, which occurs after the recruitment of innate and adaptive immune cells to the injury site, is composed of four stages of tissue repair: hemostasis, inflammation, cell proliferation and repair, and tissue remodeling 3 .
Inflammation, an important healing step that occurs between 24 and 72 hours after hemostasis, involves the recruitment of inflammatory cells to the injured site, particularly myeloid cells that contribute to several phases of the immune response.
Neutrophils and macrophages, the main myeloid cell types L-arginine metabolism has been described in the activation of myeloid cells. This dibasic amino acid is synthesized de novo from proline, glutamine or glutamate 5 . Advances in nutritional therapy have suggested that dietary supplementation with L-arginine strengthens the immune system due to the participation of L-arginine in protein synthesis, signaling and cell proliferation 6 . However, the effect of L-arginine supplementation on the immune system is still unclear, and its therapeutic application has been controverse. L-arginine can be catabolized by nitric oxide synthase (NOS) or arginase (ARG), producing nitric oxide (NO) and L-citrulline or urea and L-ornithine, respectively 7 .
In mammals, ARG exists in two different isoforms, type I arginase (ARG1), a cytosolic enzyme, and type II arginase (ARG2), a mitochondrial enzyme. L-arginine metabolism by ARG promotes fibroblast replication and collagen production, which are important in the early phases of wound healing 8 .
Three different NOS isoforms have been described, differing in their cellular location, catalytic properties and inhibitors. NOS1, also known as nNOS, is prevalent in nervous tissue, whereas NOS2 or iNOS, the inducible form, is present in a range of immune cells and NOS3, or eNOS, can be found in endothelia. NOS isoforms are responsible for the synthesis of NO, which is not only a potent microbicidal mediator of the immune system but it is also a regulator of immediate epithelialization, vascular tone, adhesion molecules expression, leukocyte adhesion, platelet aggregation and angiogenesis 9, 10 . Previous works, in animal models or humans, have suggested that NO is an important constituent of the inflammatory phase of the healing process and water access ad libitum, at 22ºC ± 1°C and were exposed to cycles of 12 hours light/darkness. Each group had five animals that were randomly distributed. At specific days describe in legends, the animals were euthanized with carbon dioxide (CO 2 ) chamber.
Blood and wound tissue were obtained by caudal puncture.
Induction of experimental diabetes
Experimental diabetes was induced by streptozotocin (STZ) (Sigma-Aldrich ® ) intraperitoneal administration, with a single dose of 60 mg/kg body weight, after mice were fasted overnight 13 . Briefly, STZ was dissolved in freshly prepared 0.025 M citrate buffer pH 4.5. Animals presenting glycemic plasmatic levels over 200 mg/dL, 7 days after STZ administration were considered diabetics.
Induction of immunosuppression
Experimental immunosuppression in mice was induced by intraperitoneal administration of hydrocortisone (União Química Nacional ® ) by two consecutive days, with a dose of 25 mg/kg body weight 22 . Immunosuppression induction was evaluated by leucocytes count in mice blood one day after the last administration of hydrocortisone in comparison with the counting acquired one day before de experimental induction.
Experimental design of Laparotomy
Anesthesia was performed by intramuscular injection with xylazine (90 mg/kg body weight) (Ceva®) and ketamine (100 mg/kg body weight) (Ceva ® ) Brielfy, for laparotomy, the abdomen was shaved, and the skin was disinfected with a 70% ethanol and 10% povidone-iodine solution. Surgical procedures were performed under aseptic conditions. A midline 3-cm long laparotomy was carried out and immediately sutured using 5-0 nylon and cylinder needles. After 5 or 10 days after the laparotomy (DAL) treatment, mice were randomly selected for euthanasia.
L-arginine treatment
Oral administration Animals were separated into two groups for these experiments: group 1 (GO1): control animals treated orally with saline solution 7 days before and 7 DAL; and group 2 (GO2): animals treated orally with L-arginine 7 days before and 7 DAL. The L-arginine solution (Vetec ® ), 2 g/kg body weight by day, was administered by gavage. The wounds were daily analyzed during 10 days after the laparotomy.
Topical administration
Healthy animals were separated into five groups for these experiments and treated in the abdominal region with either glycerol only (GT1, n = 5) or a dispersion of L-arginine in glycerol at concentrations of 5% (GT2, n = 5), 10% (GT3, n = 5), 15% (GT4, n= 5) and 40% (GT5, n = 5). Diabetic mice were separated in three groups and the treated glycerol only (GD1, n=5) or with L-arginine at 10% (GD2, n=5) or 15% (GD3, n=5). Immunosuppressed animals were also separated in three groups and treated as described above with glycerol only (GI1, n=5) or L-arginine at 10% (GI2, n=5) or 15% (GI3, n=5). Each animal received 0.5 g of glycerol or L-arginine dispersion topically every day from 7 days before to 5 DAL. After this period, mice were randomly selected for euthanasia and wounds were analyzed.
Biochemical parameters
Levels of blood urea nitrogen (BUN), creatinine, alkaline phosphatase, pyruvic acid and oxaloacetic glutamic transaminases were determined from blood samples of animals from groups 1 and 2, collected under anesthesia. Samples were analyzed by spectrometry assay using the Cobas ® analyzer (Roche/Hitachi).
Wound analysis
Tissue preparation Fragments (3 x 3 cm) of the abdominal tissue containing the scar or normal tissue were removed and fixed in neutral buffered formalin for 6 hours, embedded by routine techniques in paraffin wax and sectioned to 5-µm thickness. Sections were subjected to hematoxylin and eosin (HE) or immunohistochemical staining.
Immunohistochemical staining
Tissue sections of 5-µm thickness were collected on gelatin-coated glass slides. The samples were immersed in 3 mM citrate buffer (pH 6.0) for 10 minutes at 120°C for antigen retrieval, incubated in 3% bovine serum albumin (BSA) and then incubated with antibodies directed against one of the following marker: TNF-α (1:75 dilution), iNOS, TGF-β, CCR-1, IL-8, and IL-10 (1:100 dilution). All antibodies were from Santa Cruz Biotechnology, Inc. The sections were incubated with secondary antibodies and streptavidin-biotin complex (DAKO, A/S, Glostrup, Denmark) for 20 minutes. Diaminobenzidine chromogen solution was added to the reactions, and a counter-stain was performed with Mayer's hematoxylin. As a negative control, 1% BSA was used in place of the primary antibody. Positive controls were also prepared according to the manufacturer's instructions.
Cell counting
The number of positively-stained cells was determined for each antibody using an integration graticule (Carl Zeiss-4740680000000-Netzmikrometer 12.5x). All cells per ten consecutive microscopic high power fields of the operatory wound fragments were counted (x100). At this magnification, each field (integration graticule) has an area equal to 0.015625 mm 2 . Results were expressed as the mean of positive cells ± standard deviation (SD) of n observations per mm 2 according to the cell counting method described in previous studies 15 .
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Statistical analysis
Data were analyzed using the one-way analysis of variance (ANOVA) test followed by Bonferroni or Dunnett's multiple comparison tests. All statistical tests were performed using the software SPSS 10.0.
Results

Effects of dietary supplementation with L-arginine on wound healing.
L-arginine supplementation was well-tolerated, as demonstrated by similar serum levels of urea, creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase in both groups of animals, GO1 (control) and GO2 (animals orally treated for 10 days with L-arginine at a dosis of 2 g/kg body weight/day), as shown in Table 1 . These results indicate that L-arginine supplementation did not affect renal or hepatic activities at the concentration used in the experiments. Control animals (GO1), orally treated with saline solution only 7 days before and 7 days after the laparotomy; GO2-Animals orally treated with L-Arginine (2 g/ kg body weight by day) 7 days before and 7 days after the laparotomy; AST-aspartate aminotransferase; ALT-alanine aminotransferase. Statistical analyses were performed by Dunnett's test (p>0.05).
Histopathological analysis of surgical wounds in group 1 mice presented an intense inflammatory process, without fibrosis appearance, and with migration of polymorphonuclear cells mainly on fifth day after the laparotomy ( Figure 1A ). On the tenth day after the laparotomy, it was observed a smaller infiltration of polymorphonuclear cells, although the healing process was incomplete ( Figure 1C ). Similar results were observed for animals supplemented with L-arginine in the pre-operatory phase only (data not shown). Animals in GO2, which received L-arginine supplementation in both pre-and post-operatory phases, exhibited an inflammatory process and polymorphonuclear cell infiltration into a smaller extent; the wound areas exhibited features of a moderate and diffuse inflammatory process without fibrosis and an increase in new vein formation on the fifth day postoperation ( Figure 1B ). On the tenth day, the wound was almost completely healed ( Figure 1D ). In addition, collagen fibers were more organized and mature in the wounds of animals from group 2 ( Figure 1E ), indicating that L-arginine has a positive effect on collagen production. Taken together, these data suggest that oral arginine treatment accelerates and enhances the healing process. Tissues of animals from GO1 (E) and GO2 (F) were stained with Masson's Trichrome (specific for collagen) 5 DAL and visualized under the microscope (x200). Immunoreactivity of iNOS (x200) in lesion areas of tissues from GO1 animals 5 DAL (G) or 10 DAL (H). Immunoreactivity of TGF-β (x200) in lesion areas of tissues from GO2 animals 5 DAL (I) or 10 DAL (J). In GO1, control animals were treated orally with saline solution 7 days before and 7 days after the laparoscopy; and in GO2, animals were treated orally with L-arginine 7 days before and 7 days after the laparoscopy.
The expression of iNOS and TGF-β, inflammatory mediators important for the tissue repair process, were also examined. Animals in GO1 exhibited high expression of iNOS on the fifth day after laparotomy compared to expression on the th day or in animals not subjected to laparotomy, as depicted 
Effect of topical administration of arginine on the wound healing process
To evaluate whether the topical administration of L-arginine could also enhance the wound healing process, healthy animals were treated with glycerol only (GT1) or with L-arginine at concentrations of 5% ( GT2), 10% (GT3), 15% (GT4) or 40% (GT5). The results are shown in Figure 3 . Animals topically treated with L-arginine showed significantly enhanced healing on the fifth day after the laparotomy. The best results were obtained when L-arginine was used at concentrations of 10% ( Figure 3B and F) and 15% ( Figure 3C and G) . In animals of the groupsGT3 and GT4, there was a decrease in polymorphonuclear cell infiltration, a markable neovascularization, inflammation, and a more intense disorganized and diffuse deposition of collagen fibers, especially in animals in GT3 ( Figure 3B and F) . In animals from the group treated with arginine at 40% concentration it was observed an intense inflammation process with predominance of polymorphonuclear cells and increased collagen deposition. H) . In GT1, control animals were treated topically with glycerol; in GT3, animals were treated with 10% L-arginine; in GT4, animals were treated with 15% L-arginine; and in GT5, animals were treated with 40% L-arginine. All animals, except for those in GT1, were treated topically with L-arginine 7 days before and 5 days after the laparotomy.
The expression of iNOS and TGF-β was measured in tissues from animals topically treated with L-arginine (Figures 4   and 5 ). The expression of iNOS in wound tissue from GT2 and GT3 animals was similar to that observed in GT5 animals ( Figures   4A and 5A) , and the expression of iNOS in the wound tissue of animals in GT4 and GT5 was higher than the control group ( Figures 4C and 5A ). All groups of animals, except GT1 (control), showed increased expression of TGF-β ( Figures 4D-F and 5B), and animals treated with L-arginine at 10% exhibited the most marked up-regulation in TGF-β expression (Figures 4D and 5B ).
FIGURE 4 -Immunoreactivity of iNOS or TGF-β in lesion areas of animals treated topically with different concentrations of L-arginine. Immunohistochemical analysis (x200) are shown for GT3 (A and D), GT4 (B and E) and GT5 (C and F). Sections were incubated with antibodies against iNOS (A-C) or TGF-β (D-F)
and stained with an avidin-biotin complex. In GT3, animals were treated with 10% L-arginine; in GT4, animals were treated with 15% L-arginine; and in GT5, animals were treated with 40% L-arginine. All animals were treated topically with L-arginine 7 days before and 5 days after the laparotomy. Other important proteins in the maintenance the of inflammatory process had their expression evaluated in animals from GT1, GT3 and GT5, including TNF-α, IL-8, IL-10 and CCR-1 ( Figure 6 ). TNF-α expression was higher in wounds tissues of animals in GT5, whereas TNF-α expression was similar in the wounds tissues of animals in GT1 and GT3 ( Figure 6A ).
IL-8 expression was lower in the wounds areas in animals from
GT3 and it was higher in the wounds areas in animals from GT5 when compared to control group ( Figure 6B ). IL-10 expression in the wounds tissues of animals in group 7 was significantly higher than in the wounds tissues of animals in GT1 ( Figure 6C ). CCR-1 expression was also down-regulated in the wounds areas of animals in GT3 and up-regulated in animals from GT5 when compared to control ( Figure 6D ). 
Comparison between topical and oral administration of L-arginine on the wound healing
Comparing both administration route, oral (GO2 euthanized 5 days after laparotomy) and topical (GT3) corresponding to same dosis administration and observation conditions in health mice submitted to laparotomy, the results
show that there were no significative difference in expression of iNOS or TGF-β between control groups, GT1 or GO1 (5 DAL).
When groups treated with 50 mg of L-arginine by day varying only the administration route, topical (GT3) or oral (GO2) 5DAL, were compared, the expression of iNOS was higher in animals topically treated, and there was an extremely significative (p < 0.0001) difference between the groups caused by the administration route. The same significative difference (p < 0.0001) was observed when the expression of TGF-β was analyzed comparing animals treated orally or topically with the same L-arginine dosis.
Discussion
Wound healing is a multi-step process that involves the coordinate action of matrix components, cytokines and growth factors 16 . Enzymes involved in L-arginine metabolism, including ARG and iNOS, are widely distributed in many different tissues.
The present study demonstrates the beneficial effects In the present work, oral or topical administration of L-arginine were evaluated in post surgical wound healing process.
The results showed a decrease in the expression of iNOS in animals in which L-arginine was orally administered in comparision to the control animals. In parallel with histopathological analysis, the results suggested that the inflammatory process was attenuated five days after laparotomy, when tissues showed a decreased NO production, and it could had decreased the immunosuppressive mecanisms associated with high NO levels. However, as the tissues were first analysed on the fifth day after laparotomy, iNOS expression could have been high in the early stages of healing, since inflammation and tissue repair start quickly following lesion manifestation. It would be in accordance with the study realized by Finnen et al. 19 that showed early healing after NO application.
By the other hand, topical administration of L-arginine at 40% was detrimental to tissue repair, as suggested by high levels of iNOS expression in tissues and histopathological analysis that indicated an acute inflammatory process. The intensity of the inflammatory process and cytokines envolved will determine if NO participates as a microbicidal or immunosuppressive agent 21 .
Filipin et al. 22 showed, in an experimental model of crush injury, Another important cytokine to the wound healing process is TGF-β, which activates genes associated with type I collagen production 24 and promotes collagen production by fibroblasts
25
.
TGF-β can promote collagen production by stimulating the arginase pathway as well as it is able to inhibit the iNOS pathway and result in an increase ornithine production by increasing the availability of arginine for arginase 26 . It was observed a significant increase in TGF-β levels in tissues of animals treated with L-arginine, either orally or topically, compared to those of control animals, and it was also observed that in topical treatment there was a higher expression of TGF-β than in the tissues of animals orally treated. It is tempting to speculate that the stimulation of macrophages with L-arginine leads to the production of TGF-β, Peranteau et al. 28 investigated if IL-10 overexpression could decrease inflammation and create an environment conducive to scarless wound healing in adults. The authors concluded that this was an approach to be taken with caution, since wound healing process is composed by a serie of tightly regulated events whose attempt manipulation may result in unintended consequences.
The results presented by the authors suggested that the IL-10 overexpression acts providing an environment supportive of a regenerative healing process that is characteristic of scarless wound healing 28 . However, despite the accelerated wound closure showed by Eming et al. 29 in IL-10 deficient mice, the mechanical strength of wounds in IL-10-deficient mice is reduced,
indicating that IL-10 affects the quality of the repaired tissue 27, 28 .
In Peranteau et al. 28 study, overexpression of IL-10 resulted in a decreased inflammatory infiltrate and a more organized collagen deposition. It is interesting to notice that when mice were topically treated with dispersion of L-arginine at 40%, there was an increase in the IL-10 expression and in this same group of animals it was observed an increased collagen deposition. Since the administration of 40% L-arginine improved the expression of iNOS, the increased expression of IL-10 could be a compensation mechanism to control the inflammatory process, but it also could has acted as a mechanism to acquire a more organized collagen deposition, as occurred in the Peranteau et al. 28 work. This, IL-10 expression control it is another rote to be investigated in the relation of L-arginine administration and collagen deposition. CCR1 gene encodes a member of the beta chemokine receptor family, which belongs to a family of G protein-coupled receptors. Among the ligands of this receptor are macrophage inflammatory protein 1 alpha, monocyte chemoattractant protein 3, and myeloid progenitor inhibitory factor-1. Chemokines are critical for the recruitment of effector immune cells to the site of inflammation 30 . The levels of CCR1, which is expressed in lymphocytes, monocytes and eosinophils, decreased in animals topically treated with 10% L-arginine. This suggests an adicional evidence of the enhanced healing in the injured tissue. Histopathological analysis demonstrated a milder inflammatory process, suggesting that a higher expression of CCR1 could have occurred in an early phase of tissue repair, which is more dependent on lymphocytes, monocytes and eosinophils. Likewise occurred in the case of the IL-10 analysis, animals treated with L-arginine at 40% showed an increasement in the CCR1 expression, what can be occurring to compensate the more intense inflammation installed in the tissue.
Conclusions
Either topical or oral administration of L-arginine improves the wound healing process. For oral treatments, on fifth day after laparotomy, with daily L-arginine administration, TGF-β production was stimulated and NO levels were lower, leading to a reduced Th1 response and increased collagen deposition in the injured area. For topical treatments, the results showed a higher level of iNOS and TGF-β on the wound environment, suggesting an accelerated healing process. Overall, these results suggest that L-arginine, either oral or topically applied, may be an important factor in the recuperation of tissues following injury, and topically applied could be even more effective in accelerate the wound healing process.
